CHVI – Sustainable Regulatory Development to Accelerate Access to HIV Vaccines

Reporting Organization:WHO - World Health Organization
Total Budget ($CAD):$ 2,000,000
Timeframe: January 14, 2010 - March 31, 2013
Status: Completion
Contact Information: Unspecified

Partner & Funder Profiles

Reporting Organization

WHO - World Health Organization

Participating Organizations


Funders (Total Budget Contribution)

Return to top


Region - Total Budget Allocation

Sub-Saharan Africa - $ 1,762,800.00 (88.14%)

North Africa - $ 237,200.00 (11.86%)

Return to top

Areas of Focus

Health - Total Budget Allocation

HIV (100 %)

Return to top


The goal of this program under the Policy and Regulatory Issues component of Canadian HIV Vaccine Initiative (CHVI) is to support activities to improve regulatory capacity in low- and middle-income countries, especially those where clinical trials are planned or ongoing. The program supports the integration of ethical review, regulation, and registration of clinical trials in Africa. It promotes and strengthens the collaboration between ethical committees and regulatory authorities in the targeted African countries. Finally, it develops training material, including e-learning tools for national regulatory authorities and ethics committees.

Return to top

Target Population

Gender and age: Unspecified
Total Direct Population: Unspecified
Return to top



Return to top

Results & Indicators

Expected Results


Achieved Results

Results achieved as of June 2013 include: The African Vaccine Regulatory Forum (AVAREF) was formalized and courses on the inspection of good clinical practices as well as on the evaluation of clinical data were provided in the 19 AVAREF member countries. A course on legislation was developed to support national review authorities in the development of the legal framework for clinical trials. This course was delivered to 17 participants representing ten low and middle-income countries. The project also strengthened monitoring practices through the development of indicators that support research ethical committees and research institutions in low and middle-income countries to meet international ethics standards when conducting research with human participants.


  • None Selected
Return to top
Return to top

Associated Projects (If applicable)

Return to top